Logo image of ALPCV.PA

CERINNOV GROUP SA (ALPCV.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALPCV - FR0013178712 - Common Stock

0.0266 EUR
0 (0%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

1

Overall ALPCV gets a fundamental rating of 1 out of 10. We evaluated ALPCV against 109 industry peers in the Machinery industry. ALPCV may be in some trouble as it scores bad on both profitability and health. ALPCV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALPCV has reported negative net income.
ALPCV had a positive operating cash flow in the past year.
In the past 5 years ALPCV reported 4 times negative net income.
Of the past 5 years ALPCV 4 years had a positive operating cash flow.
ALPCV.PA Yearly Net Income VS EBIT VS OCF VS FCFALPCV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M -3M -4M

1.2 Ratios

ALPCV's Return On Assets of -22.53% is on the low side compared to the rest of the industry. ALPCV is outperformed by 88.99% of its industry peers.
ALPCV's Return On Equity of -348.45% is on the low side compared to the rest of the industry. ALPCV is outperformed by 93.58% of its industry peers.
Industry RankSector Rank
ROA -22.53%
ROE -348.45%
ROIC N/A
ROA(3y)-7.9%
ROA(5y)-10.42%
ROE(3y)-118.87%
ROE(5y)-95.67%
ROIC(3y)N/A
ROIC(5y)N/A
ALPCV.PA Yearly ROA, ROE, ROICALPCV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

ALPCV has a Gross Margin of 59.85%. This is amongst the best in the industry. ALPCV outperforms 80.73% of its industry peers.
ALPCV's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ALPCV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5Y-1.33%
ALPCV.PA Yearly Profit, Operating, Gross MarginsALPCV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

0

2. Health

2.1 Basic Checks

ALPCV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALPCV has been increased compared to 1 year ago.
Compared to 5 years ago, ALPCV has more shares outstanding
Compared to 1 year ago, ALPCV has a worse debt to assets ratio.
ALPCV.PA Yearly Shares OutstandingALPCV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
ALPCV.PA Yearly Total Debt VS Total AssetsALPCV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -1.03, we must say that ALPCV is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.03, ALPCV is not doing good in the industry: 80.73% of the companies in the same industry are doing better.
The Debt to FCF ratio of ALPCV is 17.81, which is on the high side as it means it would take ALPCV, 17.81 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALPCV (17.81) is worse than 72.48% of its industry peers.
ALPCV has a Debt/Equity ratio of 3.21. This is a high value indicating a heavy dependency on external financing.
ALPCV has a Debt to Equity ratio of 3.21. This is amonst the worse of the industry: ALPCV underperforms 91.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.21
Debt/FCF 17.81
Altman-Z -1.03
ROIC/WACCN/A
WACC4.47%
ALPCV.PA Yearly LT Debt VS Equity VS FCFALPCV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

ALPCV has a Current Ratio of 0.88. This is a bad value and indicates that ALPCV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ALPCV (0.88) is worse than 92.66% of its industry peers.
ALPCV has a Quick Ratio of 0.88. This is a bad value and indicates that ALPCV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.65, ALPCV is not doing good in the industry: 83.49% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.65
ALPCV.PA Yearly Current Assets VS Current LiabilitesALPCV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

1

3. Growth

3.1 Past

The earnings per share for ALPCV have decreased strongly by -3750.00% in the last year.
Looking at the last year, ALPCV shows a very negative growth in Revenue. The Revenue has decreased by -14.42% in the last year.
Measured over the past years, ALPCV shows a decrease in Revenue. The Revenue has been decreasing by -2.66% on average per year.
EPS 1Y (TTM)-3750%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1525%
Revenue 1Y (TTM)-14.42%
Revenue growth 3Y6.78%
Revenue growth 5Y-2.66%
Sales Q2Q%-26.28%

3.2 Future

Based on estimates for the next years, ALPCV will show a very negative growth in Earnings Per Share. The EPS will decrease by -41.42% on average per year.
Based on estimates for the next years, ALPCV will show a decrease in Revenue. The Revenue will decrease by -0.06% on average per year.
EPS Next Y-171.43%
EPS Next 2Y-41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y-0.06%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALPCV.PA Yearly Revenue VS EstimatesALPCV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 5M 10M 15M
ALPCV.PA Yearly EPS VS EstimatesALPCV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALPCV. In the last year negative earnings were reported.
Also next year ALPCV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALPCV.PA Price Earnings VS Forward Price EarningsALPCV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALPCV is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.44
EV/EBITDA N/A
ALPCV.PA Per share dataALPCV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

ALPCV's earnings are expected to decrease with -41.42% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.42%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALPCV!.
Industry RankSector Rank
Dividend Yield 0%

CERINNOV GROUP SA

EPA:ALPCV (12/23/2025, 7:00:00 PM)

0.0266

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)09-24 2025-09-24
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap135.13K
Revenue(TTM)12.41M
Net Income(TTM)-3.38M
Analysts40
Price Target0.82 (2982.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)10%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.44
P/OCF 0.14
P/B 0.14
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.73
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.06
FCFY229.41%
OCF(TTM)0.19
OCFY717.84%
SpS2.44
BVpS0.2
TBVpS-0.62
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -22.53%
ROE -348.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.85%
FCFM 2.5%
ROA(3y)-7.9%
ROA(5y)-10.42%
ROE(3y)-118.87%
ROE(5y)-95.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5Y-1.33%
F-Score5
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 3.21
Debt/FCF 17.81
Debt/EBITDA N/A
Cap/Depr 32.35%
Cap/Sales 5.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.65
Altman-Z -1.03
F-Score5
WACC4.47%
ROIC/WACCN/A
Cap/Depr(3y)51.46%
Cap/Depr(5y)60.5%
Cap/Sales(3y)5.11%
Cap/Sales(5y)7.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3750%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1525%
EPS Next Y-171.43%
EPS Next 2Y-41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.42%
Revenue growth 3Y6.78%
Revenue growth 5Y-2.66%
Sales Q2Q%-26.28%
Revenue Next YearN/A
Revenue Next 2Y-0.06%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-460.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-44.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.68%
OCF growth 3Y22.79%
OCF growth 5YN/A

CERINNOV GROUP SA / ALPCV.PA FAQ

Can you provide the ChartMill fundamental rating for CERINNOV GROUP SA?

ChartMill assigns a fundamental rating of 1 / 10 to ALPCV.PA.


What is the valuation status for ALPCV stock?

ChartMill assigns a valuation rating of 2 / 10 to CERINNOV GROUP SA (ALPCV.PA). This can be considered as Overvalued.


What is the profitability of ALPCV stock?

CERINNOV GROUP SA (ALPCV.PA) has a profitability rating of 2 / 10.


What is the earnings growth outlook for CERINNOV GROUP SA?

The Earnings per Share (EPS) of CERINNOV GROUP SA (ALPCV.PA) is expected to decline by -171.43% in the next year.